🇫🇷 France Country × Condition
neoplasms Clinical Trials in France
Active clinical trials for neoplasms with research sites in France. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇫🇷 France
Active Trials in France (4)
NCT06149312
Recruiting
Feasibility of an Advance Care Planning Intervention
Enrollment
120 pts
Country
🇫🇷 France
Institut de cancérologie Strasbourg...
View Trial → NCT05066139
Recruiting
Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G)
Enrollment
144 pts
Country
🇫🇷 France
Centre Paul Strauss
View Trial → NCT04746729
Recruiting
Health Effects of CArdiac FluoRoscopy and MOderN RadIotherapy in PediatriCs - Radiotherapy
Enrollment
2,670 pts
Country
🇫🇷 France
Institut National de la Santé Et de...
View Trial → NCT05592626 Phase 1, Phase 2
Recruiting
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Enrollment
365 pts
Country
🇫🇷 France
Marengo Therapeutics, Inc.
View Trial → Frequently Asked Questions
How many neoplasms clinical trials are active in France?
There are currently 4 active clinical trials for neoplasms with sites in France, of which 4 are actively recruiting patients.
How can I join a neoplasms clinical trial in France?
To join a neoplasms clinical trial in France, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in France directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are neoplasms trials in France?
Active neoplasms trials in France span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.